Published in Women's Health Weekly, July 13th, 2006
Investigators at Baylor College of Medicine in Houston report, "We compared the effectiveness of SurePath (TriPath Imaging Burlington. NC) with that of conventional Papanicolaou smears (CP) to demonstrate microorganisms in cervicovaginal smears."
"Samples from 904 randomly selected cases were examined at the Medical Center of Louisiana clinics for 2 years -- the year before and the year after the implementation of SurePath," wrote H. Takei and colleagues. "One observer reviewed the CP and SurePath preparations for detection of microorganisms....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly